SCA
DGX icon

SMH Capital Advisors’s Quest Diagnostics DGX Stock Holding History

SMH Capital Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,462
Closed -$203K – 55
2023
Q1 		$203K Sell
1,462
-197
-12% -$28.2K 1.21% 38
2022
Q4 		$260K Sell
1,659
-1,596
-49% -$229K 0.38% 43
2022
Q3 		$399K Buy
3,255
+3
+0.1% +$395 0.6% 22
2022
Q2 		$432K Buy
3,252
+495
+18% +$67.5K 0.58% 24
2022
Q1 		$377K Buy
2,757
+186
+7% +$25.9K 0.61% 25
2021
Q4 		$445K Buy
2,571
+50
+2% +$7.61K 0.88% 20
2021
Q3 		$366K Hold
2,521
– – 0.67% 27
2021
Q2 		$333K Buy
2,521
+103
+4% +$13.5K 0.67% 31
2021
Q1 		$310K Buy
+2,418
New +$298K 0.69% 32

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SMH Capital Advisors's DGX Position: Q2 2023 in Review

SMH Capital Advisors sold out of Quest Diagnostics (DGX) in Q2 2023, closing a stake of 1,462 shares — an estimated $203K sold.

SMH Capital Advisors first reported a position in DGX in Q1 2021 and held it in 9 quarters. The position peaked at $445K in Q4 2021. 819 funds tracked by Wall St. Rank hold DGX as of Q2 2023.

  • SMH Capital Advisors reported no remaining Quest Diagnostics position as of Q2 2023 after selling out during the quarter.
  • SMH Capital Advisors sold 1,462 Quest Diagnostics shares in Q2 2023, an estimated $203K.
  • SMH Capital Advisors first reported a position in Quest Diagnostics in Q1 2021 and held it in 9 quarters.
  • SMH Capital Advisors's Quest Diagnostics position peaked at $445K in Q4 2021.
  • 819 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2023.

Based on SMH Capital Advisors's 13F filing for Q2 2023, filed 8 Aug 2023.